Patient IBS Characteristics and Treatment.
Patient IBS Characteristics and Treatment.
| IBS Characteristic | Ethnicity | P Value | |
|---|---|---|---|
| Arabs (n=91) | Jews (n=176) | ||
| IBS subtype | |||
| Unclassified | 7 (7.7) | 31 (17.6) | <0.001 |
| With predominant diarrhea | 10 (11) | 69 (39.2) | |
| With predominant constipation | 26 (28.6) | 29 (16.5) | |
| With mixed bowel habits | 48 (52.7) | 47 (26.7) | |
| Associated comorbidities/symptoms | |||
| Bloating | 88 (96.7) | 149 (84.7) | 0.003 |
| Sleep disorders | 32 (35.2) | 34 (19.3) | 0.004 |
| Anxiety | 28 (30.8) | 31 (17.6) | 0.014 |
| Gastroesophageal reflux disease | 36 (39.6) | 40 (22.7) | 0.004 |
| Disease duration, median (IQR), years | 10 (4–15) | 6.5 (2.7–15) | 0.06 |
| Medication treatments | |||
| Any medication | 87 (95.6) | 119 (67.6) | <0.001 |
| Painkillers* | 34 (37.4) | 49 (27.8) | 0.11 |
| Antidepressant | 41 (45.1) | 37 (21) | <0.001 |
| Sleep medication | 30 (33) | 15 (8.5) | <0.001 |
| Cannabis | 3 (3.3) | 15 (8.5) | 0.10 |
| Probiotics | 36 (39.6) | 64 (36.4) | 0.60 |
| Rifaximin | 5 (5.5) | 7 (4.0) | 0.57 |
| Antidiarrheal | 9 (9.9) | 20 (11.4) | 0.71 |
| Antispasmodic | 34 (37.4) | 41 (23.3) | 0.01 |
| Laxative | 28 (30.8) | 11 (6.3) | <0.001 |
| Pancreatic enzymes | 2 (2.2) | 2 (1.1) | 0.60 |
| Fiber supplement | 53 (58.2) | 16 (9.1) | <0.001 |
| Non-medical treatment | |||
| Emotional support | 10 (11) | 40 (22.7) | 0.02 |
| Homeopathic/alternative | 77 (84.6) | 50 (28.4) | <0.001 |
| Psychiatric treatment | 11 (12.1) | 15 (8.5) | 0.35 |
| Does the treatment help? | |||
| No | 12 (13.2) | 43 (29.1) | 0.01 |
| Partially | 59 (64.8) | 79 (53.4) | |
| Yes | 20 (22) | 26 (17.5) | |